Juthaporn Cowan profile picture

Contact Information

Juthaporn Cowan, MD, PhD, FRCPC
(613)737-8899 ext. 79617

Administrative Coordinator:
Andrea Trinidad
atrinidad@toh.ca

ORCID logo https://orcid.org/0000-0001-6648-5109

Juthaporn Cowan

Associate Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Assistant Professor, Department of Medicine, Division of Infectious Diseases
University of Ottawa
Assistant Professor, Department of Biochemistry, Microbiology, and Immunology
University of Ottawa

Research Interests

  • Prevention of infections in non-HIV immunodeficiency particularly post-transplantation
  • Vaccination in immunocompromised patients
  • Immunotherapy for primary and secondary immunodeficiency diseases
  • Cellular and molecular immunology of infectious diseases
  • Microbial pathogenesis and host immune defence mechanism 
       

Brief Biography

Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.

Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa.

Drs. D. William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa. The clinic is expanding and is served as a resource for clinical research.

Selected Publications

Cowan, J. (2020). Ontario Immunoglobulin Treatment Program. ORBCoN Newsletter. May 2020 issue. Website: https://transfusionontario.org/en/documents/?cat=the-orbcon-report

Cowan, J, Cameron, D.W. (2020). Measles post exposure prophylaxis (PEP): IVIG versus other IG products. Which one should we use? ORBCoN Newsletter. March 2020 issue. Website: https://transfusionontario.org/en/documents/?cat=the-orbcon-report

Cowan, J
., Bonagura, V., Lugar, P., Maglione, P., Patel, N., Vinh, D., Hofmann, J., Praus, M., Rojavin, M. (2020). Safety and tolerability of manual push administration of subcutaneous IgPro20 at high infusion rates in patients with primary immunodeficiency: findings from the manual push administration cohort of the HILO study. Journal of Clinical Immunology. 40(7):1-10. DOI 10.1007/s10875-020-00876-6

Cowan, J., Bennett, A., Fergusson, N, McLean, C., Mallick, R., Cameron, DW., Knoll, G. (2018). Incidence rate of post-kidney transplant infection: a retrospective cohort study examining infection rates at a large Canadian multicenter tertiary-care facility. Canadian Journal of Kidney Health and Disease. DOI: 10.1177/2054358118799692

Cowan, J., Mulpuru, S., Aaron, S., Alvarez, G., Giulivi, A., Corrales-Medina, V., Thiruganasambandamoorthy, V., Thavorn, K., Mallick, R., Cameron, DW. (2018). Study protocol: a randomized, double blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations. Pilot and Feasibility. DOI: 10.1186/s40814-018-0327-z

Diseases, conditions and populations of interest





Research and clinical approaches